GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cldn5 | decreases expression | EXP | | 6480464 | CTD | cyanoginosin LR results in decreased expression of CLDN5 protein | PMID:34416350 | Cldn5 | multiple interactions | EXP | | 6480464 | CTD | [cyanoginosin LR co-treated with LCN2 protein] results in decreased expression of CLDN5 protein; [Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of CLDN5 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[cyanoginosin LR co-treated with LCN2 protein] results in decreased expression of CLDN5 protein]; NLRP3 protein affects the reaction [[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of CLDN5 protein]] | PMID:34416350 | |
Go Back to source page | Continue to Ontology report |